BOXBOROUGH MA. –RedShiftBioAnalytics, Inc. (RedShiftBio), a provider of innovative analytical solutions for the measurement of protein characterization and protein concentration used in biotherapeutic drug development and manufacturing, proudly announces the appointment of Tom O’Lenic as its new Chief Executive Officer (CEO). With over two decades of experience in commercial leadership and management roles, O’Lenic brings […]

WALTHAM, Mass. — NanoMosaic, the multiplex and multi-omic quantification company, today announced the expanded capabilities and availability of assays optimized on its Tessie™ system for use in gene therapy applications. The platform combines the ability to quantify proteins and nucleic acids in a single run, enabling the simultaneous detection and characterization of adeno-associated virus (AAV) […]

Validated, off-the-shelf kit for multiplexed seasonal hemagglutinin (HA) detection and quantification addresses the unique challenges faced by vaccine developers and manufacturers. BOULDER, CO InDevR Inc., a global leader in vaccine testing and multiplexed assay development for vaccine manufacturers, is excited to announce the launch of OmniFlu HA, a validated, off-the-shelf kit for seasonal influenza vaccine […]

KITCHENER, ON, CANADA — Nicoya Lifesciences Inc., a pioneering life sciences instrument company specializing in innovative biosensor technologies, is pleased to announce the launch of flexible software configuration packages for their flagship Alto™ Digital Surface Plasmon Resonance (Digital SPR™) system. These packages are designed to provide access to the innovative Alto system at a cost-effective price […]

InDevR Inc., a global leader in vaccine analytical tools and method development, is excited to announce the launch of its latest offering, Expert Services. Expert Services provides vaccine manufacturers with tailored workflow solutions to help address and eliminate development bottlenecks and accelerate the analysis and validation of seasonal vaccines and novel biotherapeutics. Expert Services is InDevR’s latest […]

NEWARK, Calif. — ACROBiosystems, one of the leading providers of innovative tools and solutions used from discovery to the clinic, has announced a new corporate initiative to support ex vivo cell manufacturing and manufacturers of innovative cell and gene therapies. In response to the shifting landscape of biologics manufacturing across the globe, this initiative is designed to […]

LEIDEN, NL – Synexa Life Sciences, a global Clinical Laboratory Services provider for the biopharma industry, announces the integration of the Olink® Target immunoassays and the Olink® Signature Q100 instrument into its extensive suite of biomarker discovery platforms.The adoption of Olink Signature Q100 represents a significant step forward in Synexa’s commitment to providing leading biomarker […]

13,000 square-meters space for Life Science business sector accommodates 11,000 pallet positions and more than 50,000 stock-keeping units New site in Cajamar, São Paulo has 2.5 times more storage capacity than the previous space in Cotia, São Paulo 13,000 square-meters space for Life Science business sector accommodates 11,000 pallet positions and more than 50,000 stock-keeping […]

FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Dave Hickey has informed the company of his intent to retire from BD, effective July 1. Hickey is currently executive vice president and president of the Life Sciences segment for BD, a position he has held since January 2021. Prior […]

Financing led by Sands Capital brings total capital raised to nearly $250 million. Fremont, CA, US – Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced today the first close of $100 million in Series C financing with the second close of an additional $28 million expected to happen within […]